Lilly’s Zepbound Resolves Sleep Apnea in 52% of Patients by Mark Eisenberg 22.06.2024 Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...
Winnipeg Biotech Company’s Breakthrough in Phage Therapy by Lilu Anderson 28.03.2024 Phage therapy, unlocking the potential of bacteria phages, is being used to treat antibiotic-resistant infections. It potentially saved a woman's ...
Adicet Bio Upgrade Sparks Investor Excitement by Terry Bingman 14.02.2024 Adicet Bio receives an upgrade from Jones Trading, raising its rating to Buy with a new price target of $6.00. ...
Coya Therapeutics Secures Key Therapy License by Lilu Anderson 13.02.2024 Clinical-stage biotech company Coya Therapeutics expands its IP portfolio with a license for a novel combination therapy using low dose ...
FDA Approves Takeda’s EoE Therapy EOHILIA by Lilu Anderson 12.02.2024 FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
My Top 5 Amazon Finds of 2024 Starting at $5 by Lilu Anderson 11.02.2024 Discover the top 5 game-changing products for 2024 in this article, including a blemish calming face serum and a sunrise ...
CalSTRS and Family Offices Embrace Life Sciences VC Firm by John Darbie 10.02.2024 John Flavin, CEO of life sciences VC firm Portal Innovations, discusses the importance of intertwining real estate investments with their ...
Greenwood Genetic Center Launches New Technology to Aid Alzheimer’s Patients by Lilu Anderson 23.01.2024 The introduction of the BioSpherix Xvivo System offers hope to those suffering from Alzheimer’s, as the technology aims to improve ...